Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections.
This report contains market size and forecasts of Cephalosporin Antibiotics API in global, including the following market information:
Global Cephalosporin Antibiotics API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cephalosporin Antibiotics API Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Cephalosporin Antibiotics API companies in 2021 (%)
The global Cephalosporin Antibiotics API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
First Generation Cephalosporins Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cephalosporin Antibiotics API include NCPC, Qilu Antibiotics, Dongying Pharmaceutical, SALUBRIS, LIVZON, CSPC, United Laboratories, LKPC and HPGC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cephalosporin Antibiotics API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cephalosporin Antibiotics API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Cephalosporin Antibiotics API Market Segment Percentages, by Type, 2021 (%)
First Generation Cephalosporins
Second Generation Cephalosporins
Third-generation Cephalosporins
Fourth Generation Cephalosporins
Global Cephalosporin Antibiotics API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Cephalosporin Antibiotics API Market Segment Percentages, by Application, 2021 (%)
Injection
Oral
Global Cephalosporin Antibiotics API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Cephalosporin Antibiotics API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cephalosporin Antibiotics API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cephalosporin Antibiotics API revenues share in global market, 2021 (%)
Key companies Cephalosporin Antibiotics API sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Cephalosporin Antibiotics API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
NCPC
Qilu Antibiotics
Dongying Pharmaceutical
SALUBRIS
LIVZON
CSPC
United Laboratories
LKPC
HPGC
Shandong Ruiying
Liaoning Meiya
Kelun
Suzhou Dongrui
Guangdong Liguo
Fuan
Orchid Pharma
Aurobindo
Nectar Lifesciences
ACS Dobfar
Novartis